Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 605 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Beactica, Janssen extend research services deal

According to the deal, Beactica will leverage Sprint drug discovery platform in identifying allosteric modulators against certain central nervous system proteins for supporting the Janssen’s discovery efforts. The

Pfizer takes over NextWave Pharmaceuticals

Through the acquisition, Pfizer has gained exclusive North American commercialization rights to the FDA approved Quillivant XR. Quillivant XR (methylphenidate hydrochloride) extended-release oral suspension is indicated to treat

KESA Partners buys NextPharma US affiliate Bioserv

The sale of Bioserv will support NextPharma’s growth strategy of focusing on its core specialty and conventional product and technology operating platform in Europe. KESA Partners managing partner

BDI recalls Isovue PFS injector syringes

The particles were observed at the end of standard stability studies on retained samples. BDI has not received any customer complaints or adverse events associated with these lots.